CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.
about
Efficient Use of a Crude Drug/Herb Library Reveals Ephedra Herb As a Specific Antagonist for TH2-Specific Chemokine Receptors CCR3, CCR4, and CCR8CCL5/RANTES contributes to hypothalamic insulin signaling for systemic insulin responsiveness through CCR5.Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature ReviewIncreased Transendothelial Transport of CCL3 Is Insufficient to Drive Immune Cell Transmigration through the Blood-Brain Barrier under Inflammatory Conditions In Vitro.Maraviroc-Mediated Lung Protection following Trauma-Hemorrhagic ShockDifferences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis.HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment.CCR5 receptor antagonists in preclinical to phase II clinical development for treatment of HIV.Cognitive Impairment and Persistent CNS Injury in Treated HIV.Treating HIV Infection in the Central Nervous System.Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patients.Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.CCL5-Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis.Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era.Astragaloside IV Alleviates Lipopolysaccharide-Induced Acute Kidney Injury Through Down-Regulating Cytokines, CCR5 and p-ERK, and Elevating Anti-Oxidative Ability.Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain.CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.Pharmacological Regulation of Neuropathic Pain Driven by Inflammatory Macrophages.Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers.CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.Introduction to Lymphocyte Trafficking in Disease.Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.
P2860
Q28828873-827BF1FB-8AB7-42E5-8AEA-61256F558FF0Q30830123-C5724891-BDFB-4CE4-86EA-FBC2677B9426Q33715659-E4164410-9D0B-45DD-9B64-485A77135413Q33775611-76B4CA43-3BF0-4958-8FAC-97B08801ED0FQ37172179-D07935CB-381C-4FD7-8927-1D3617635DEBQ37697448-26D2014C-D788-406E-ACDD-E102BF42E383Q37720509-83D1BB16-EBA8-4AD9-B605-704F3758C7DEQ38803127-D3C93C4D-38AC-4427-ADB4-5C149D1E13F1Q38836472-171272FD-AD5E-44FD-ABE8-B5E2D0BE85DDQ39077816-42ACBA8F-88C5-46A6-A3D6-BF862B0F9EE8Q39366403-75548B4F-052C-438D-ACE5-6C3DE9662510Q40151022-35FA501A-DEFE-4F4C-9611-8135DC43D993Q41471364-71BBEDE4-AA15-4A06-9E42-1EA2B483BDCDQ41928050-D2139A67-262A-4956-B52A-FF770BD00D6DQ42293209-372879FC-C084-4745-84A0-1C368493FF8BQ42689787-5E084A3E-9C58-431A-912A-194B596081D7Q45073147-6C9CF0EE-FE16-4AD2-9A3C-3328FF37060EQ47101484-F07FA8AE-4D20-4DE7-AE6F-8026F15D29E1Q47800411-84C9A4C5-D4D7-4EB7-AD1D-0EA894A13B9CQ47894419-D88B4E49-A783-488C-94DD-B7E03D7D5461Q52695639-D14878E9-1E8C-4C57-8741-083383691394Q55052878-9E0C5C0B-9CA1-4061-98E9-B2586B184E7DQ55449054-F52801BF-0825-4515-BD52-FE5D8B23DEB8
P2860
CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.
@en
type
label
CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.
@en
prefLabel
CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.
@en
P2860
P50
P1476
CCR5 blockade for neuroinflammatory diseases--beyond control of HIV
@en
P2093
David Brassat
P2860
P2888
P304
P356
10.1038/NRNEUROL.2015.248
P407
P577
2016-01-18T00:00:00Z
P5875
P6179
1028210176